Agentix (AGTX) Revenue (2015 - 2021)
Agentix's (AGTX) quarterly Revenue came in at $1240.0 in Q3 2021, down 44.89% on a QoQ basis from $2250.0 in Q1 2017.
Agentix (AGTX) Revenue (2015 - 2021) Analysis & Trends
Agentix (AGTX) has 4 years of Revenue data on file, last reported at $1240.0 in Q3 2021.
- Quarterly Revenue changed N/A year-over-year to $1240.0 in Q3 2021, while the trailing twelve-month figure through Mar 2023 was $1240.0 (changed N/A YoY) and the FY2022 annual result came in at $1240.0, changed N/A from the prior year.
- Revenue eased to $1240.0 in Q3 2021, from $2250.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $2250.0 in Q1 2017 to a low of $1240.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2021 | 1,240.00 |
| Feb 28, 2017 | 2,250.00 |
| Aug 31, 2016 | 893.00 |
| May 31, 2016 | 12,250.00 |
| Feb 29, 2016 | 15,000.00 |
| Nov 30, 2015 | 15,000.00 |
| Aug 31, 2015 | 17,250.00 |
| May 31, 2015 | 11,125.00 |